Globus Medical Stock EBITDA
| GMED Stock | USD 50.35 0.40 0.79% |
Globus Medical fundamentals help investors to digest information that contributes to Globus Medical's financial success or failures. It also enables traders to predict the movement of Globus Stock. The fundamental analysis module provides a way to measure Globus Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Globus Medical stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 401 M | 221.9 M |
Globus | EBITDA |
Globus Medical Company EBITDA Analysis
Globus Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Globus Medical EBITDA | 401.03 M |
Most of Globus Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Globus Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Globus EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Globus Medical is extremely important. It helps to project a fair market value of Globus Stock properly, considering its historical fundamentals such as EBITDA. Since Globus Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Globus Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Globus Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Globus EBITDA Historical Pattern
Today, most investors in Globus Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Globus Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Globus Medical ebitda as a starting point in their analysis.
Globus Medical EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Globus Ebitda
Ebitda |
|
According to the company disclosure, Globus Medical reported earnings before interest,tax, depreciation and amortization of 401.03 M. This is 54.29% lower than that of the Health Care Equipment & Supplies sector and 37.59% lower than that of the Health Care industry. The ebitda for all United States stocks is 89.71% higher than that of the company.
Globus EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Globus Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Globus Medical could also be used in its relative valuation, which is a method of valuing Globus Medical by comparing valuation metrics of similar companies.Globus Medical is currently under evaluation in ebitda category among related companies.
Globus Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Globus Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Globus Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Globus Medical's value.| Shares | Champlain Investment Partners, Llc | 2023-12-31 | 2 M | Geode Capital Management, Llc | 2023-12-31 | 1.9 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 1.8 M | Norges Bank | 2023-12-31 | 1.8 M | Gw&k Investment Management, Llc | 2023-12-31 | 1.8 M | Burgundy Asset Management Ltd | 2023-12-31 | 1.7 M | Marshall Wace Asset Management Ltd | 2023-12-31 | 1.6 M | Van Berkom And Associates Inc | 2023-12-31 | 1.6 M | Geneva Capital Management | 2023-12-31 | 1.4 M | Vanguard Group Inc | 2023-12-31 | 11.3 M | Blackrock Inc | 2023-12-31 | 10.8 M |
Globus Fundamentals
| Return On Equity | 0.0421 | ||||
| Return On Asset | 0.0477 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 6.82 B | ||||
| Shares Outstanding | 112.94 M | ||||
| Shares Owned By Insiders | 0.79 % | ||||
| Shares Owned By Institutions | 96.97 % | ||||
| Number Of Shares Shorted | 7.76 M | ||||
| Price To Earning | 73.16 X | ||||
| Price To Book | 1.75 X | ||||
| Price To Sales | 4.46 X | ||||
| Revenue | 1.57 B | ||||
| Gross Profit | 759.12 M | ||||
| EBITDA | 401.03 M | ||||
| Net Income | 122.87 M | ||||
| Cash And Equivalents | 408.01 M | ||||
| Cash Per Share | 4.10 X | ||||
| Total Debt | 520.4 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.10 X | ||||
| Book Value Per Share | 29.32 X | ||||
| Cash Flow From Operations | 243.5 M | ||||
| Short Ratio | 7.36 X | ||||
| Earnings Per Share | 1.07 X | ||||
| Price To Earnings To Growth | 1.75 X | ||||
| Target Price | 61.46 | ||||
| Number Of Employees | 5 K | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 6.82 B | ||||
| Total Asset | 5.09 B | ||||
| Retained Earnings | 1.14 B | ||||
| Working Capital | 1.52 B | ||||
| Current Asset | 544.8 M | ||||
| Current Liabilities | 82.69 M | ||||
| Net Asset | 5.09 B |
About Globus Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Globus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Globus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Globus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Globus Medical Piotroski F Score and Globus Medical Altman Z Score analysis. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share 1.07 | Revenue Per Share 13.87 | Quarterly Revenue Growth 1.246 | Return On Assets 0.0477 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.